EMA endorses use of Moderna COVID-19 vaccine in teens

FAJAR
Duhur
Asr
Maghrib
Isha

°C,

Sharjah 24 – Reuters: Europe's medicines regulator on Friday recommended approving the use of Moderna's COVID-19 vaccine in 12- to 17-year olds, paving the way for it to become the second shot okayed for adolescent use in the European Union.

The use of the vaccine, branded Spikevax, will be the same in children from 12 to 17 years as in people aged 18 and above, the European Medicines Agency (EMA) said.

EMA endorses use of Moderna COVID-19 vaccine in teens

Sharjah 24 – Reuters: Europe's medicines regulator on Friday recommended approving the use of Moderna's COVID-19 vaccine in 12- to 17-year olds, paving the way for it to become the second shot okayed for adolescent use in the European Union.

Related Topics

More on this Topic

Taiwan orders further 36 mln Moderna vaccine doses

MoHAP approves emergency registration of Moderna Covid-19 Vaccine

Study recommends vaccine mix for better protection

J&J's COVID-19 vaccine shows promise against Delta variant